Projects in research unit
Showing records 1 - 14 (of 14)
Principal Investigator
Title
Organization
Status
ID
Walker, Ulrich A.
NETosis and mitochondrial DNA in the pathogenesis, diagnosis and activity of systemic lupus erythematosus and ANCA-associated vasculitis. Bereich Medizinische Fächer (Klinik) / Rheumatologie FPS (Tyndall)
Completed
4500645
Walker, Ulrich A.
SCQM Database, Substudy: Safety and efficacy of Orencia - Evaluation of a novel screening strategy for rheumatoid arthritis with 3rd line DMARD. Rheumatologie FPS (Tyndall)
Completed
1201553
Walker, Ulrich A.
ESBA-105 Study. Anti-TNF scFv antibody for severe osteoarthritis of the knee. Rheumatologie FPS (Tyndall)
Completed
1201549
Walker, Ulrich A.
Focus on Capillaroscopic Ulcer Index in Scleroderma Rheumatologie FPS (Tyndall)
Completed
1201548
Walker, Ulrich A.
Somatisch erworbene Mitochondrienläsionen bei idiopathischer und Sklerodermie-assoziierter Lungenfibrose Rheumatologie FPS (Tyndall)
Completed
1201533
Walker, Ulrich A.
GO-MORE Study An open-label study assessing the addition of subcutaneous Golimumab to conventional disease-modfifying antirheumatic drug (DMARD) therapy in biologic-naive subjects with rheumatoid arthritis. Rheumatologie FPS (Tyndall)
Completed
1201481
Walker, Ulrich A.
Multinational, open-label study to evaluate the safety, tolerability and efficacy of Tocilizumab in patients with active rheumatoid arthritis on background non-biologic DMARDs who have an inadequate response to current non-biologic DMARD and/or anti-TNF-alpha therapy. Rheumatologie FPS (Tyndall)
Completed
1201413
Walker, Ulrich A.
EUSTAR Meds-Online / Online database Rheumatologie FPS (Tyndall)
Completed
1201412
Tyndall, Alan de Vere
A double-blind, randomised placebo-controlled Phase I/IIa study to investigate the saftey, tolerability and efficacy on pain of intraarticular ESBA105 applied to patients with severely painful osteoarthritis of the knee. Rheumatologie FPS (Tyndall)
Completed
1201336
Walker, Ulrich A.
EBI-2 bei Lupus und SLE (EBV-induced peptide-2). Rheumatologie FPS (Tyndall)
Completed
1201323
Walker, Ulrich A.
VEDOSS - Very early diagnosis of systemic sclerosis. Rheumatologie FPS (Tyndall)
Completed
1201322
Walker, Ulrich A.
SCQM Biobank, coupled with SCQM cohort of patients with rheumatoid arthritis. Rheumatologie FPS (Tyndall)
Completed
1201320
Walker, Ulrich A.
Cell Free DNA and Neutrophil Extracellular Trap (NET) generation in the pathogenesis of rheumatoid arthritis. Rheumatologie FPS (Tyndall)
Completed
1201319
Tyndall, Alan de Vere
An open-label study assessing the addition of subcutaneous Golimumab to conventional DMARD therapy in biologic naive subjects with rheumatoid arthritis (Part 1), followed by a randomized study assessing the value of combined intravenous and subcutaneous Golimumab administration aimed at inducing and maintaining remission (Part 2). Rheumatologie FPS (Tyndall)
Completed
1201122
Showing records 1 - 14 (of 14)
MCSS v5.8 PRO. 0.034 sec, queries - 0.000 sec
©Universität Basel | Impressum
|
11/05/2024
Research Database / FORSCHUNGSDATENBANK
